In a prospective, population-based cohort study, researchers examined the association between chronic kidney disease and dementia before and after transient ischemic attack and stroke.
Researchers sought to compare ticagrelor and aspirin with clopidogrel and aspirin in patients with acute minor ischemic stroke or transient ischemic attack in preventing recurrent ischemic strokes and death.
The Canadian Transient Ischemic Attack Score effectively stratifies seven-day stroke risk among emergency department patients with TIA.
Study researchers investigated the population based incidence of transient ischemic attack (TIA) and the long-term stroke risk trends following TIA.
The admission rates of ischemic stroke and TIA were lower during the first weeks of the 2020 COVID-19 lockdown compared with those of 2017-2019.
Study authors compared the safety and efficacy of oral anticoagulants vs antiplatelets in patients with stroke and supracardiac atherosclerosis.
Ticagrelor-aspirin is associated with a reduced risk for the composite of stroke or death within 30 days of mild-to-moderate acute noncardioembolic ischemic stroke or TIA.
A panel prepared a comprehensive set of practice implications for clinicians caring for adults with acute ischemic stroke with confirmed or suspected of having COVID-19.
Patients with transient ischemic attack with high brain natriuretic peptide values are more likely to have atrial fibrillation.
The combination of higher serum oxLDL and LDL levels was found to be associated with an increased risk for recurrent stroke and poor functional outcomes in patients who have had minor stroke or are at high risk for TIAs.
